14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £1,346.00 £1,346.00 Thursday, 8th Feb 2024 ERGO.L stock ended at £1,346.00. During the day the stock fluctuated 0% from a day low at £1,346.00 to a day high of £1,346.00.
90 days £1,346.00 £1,348.00
52 weeks £895.00 £1,378.00

Historical Entia Biosciences Inc prices

Date Open High Low Close Volume
Feb 08, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Feb 07, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Feb 06, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Feb 05, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Feb 01, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 31, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 30, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 29, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 26, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 25, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 24, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 23, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 22, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 19, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 18, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 17, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 16, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 15, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 12, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 11, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 10, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 09, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 08, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 05, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Jan 04, 2024 £1,346.00 £1,346.00 £1,346.00 £1,346.00 0
Click to get the best stock tips daily for free!

About Entia Biosciences Inc

Entia Biosciences Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance service... ERGO.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT